Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
Daisy Yan, Robert Borucki, Richard D. Sontheimer, et al.
Lupus Science & Medicine (2020) Vol. 7, Iss. 1, pp. e000430-e000430
Open Access | Times Cited: 10

Showing 10 citing articles:

Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects
Everton Carlos Siviero do Vale, Lucas Campos Garcia
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 3, pp. 355-372
Open Access | Times Cited: 31
Clinical Applications of Polypodium leucotomos (Fernblock®): An Update
Azahara Rodríguez-Luna, Alicia Zamarrón, Ángeles Juarranz, et al.
Life (2023) Vol. 13, Iss. 7, pp. 1513-1513
Open Access | Times Cited: 9
Quinacrine Ameliorates Cisplatin-Induced Renal Toxicity via Modulation of Sirtuin-1 Pathway
Nada F. Abo El‐Magd, Hasnaa Ali Ebrahim, Mohamed El‐Sherbiny, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10660-10660
Open Access | Times Cited: 16
Emerging Therapies in Cutaneous Lupus Erythematosus
Grant Sprow, Joshua Dan, Joseph F. Merola, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy
Xin Pan, Teng-yu Mao, Yan-Wen Mai, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5561-5561
Open Access | Times Cited: 12
Clinical Applications of Polypodium leucotomos (Fernblock®): An Update
Azahara Rodríguez-Luna, Alicia Zamarrón, Ángeles Juarranz, et al.
(2023)
Open Access | Times Cited: 4
Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials
Majid Zeidi, Kristen L. Chen, Jay Patel, et al.
Lupus (2022) Vol. 31, Iss. 4, pp. 472-481
Open Access | Times Cited: 7
Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations
Briana Heinly, Astia Allenzara, Matthew F. Helm, et al.
Drugs & Aging (2023) Vol. 41, Iss. 1, pp. 31-43
Closed Access | Times Cited: 2
Hydroxychloroquine for the treatment of cutaneous lupus erythematosus
Fukumi Furukawa
Trends in Immunotherapy (2021) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 2
Lúpus eritematoso cutâneo: revisão dos aspectos etiopatogênicos, clínicos, diagnósticos e terapêuticos
Everton Carlos Siviero do Vale, Lucas Campos Garcia
(2023) Vol. 98, Iss. 3, pp. 355-372
Open Access
Page 1

Scroll to top